Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Total Debt (2012 - 2026)

Incyte's (INCY) quarterly Total Debt came in at $38.8 million in Q2 2026, down 17.14% YoY from $46.8 million in Q2 2025, and down 1.45% on a QoQ basis from $39.4 million in Q1 2026.

Analysis

Incyte (INCY) Total Debt (2012 - 2026) Analysis & Trends

Incyte (INCY) has 14 years of Total Debt data on file, last reported at $38.8 million in Q2 2026.

  • Quarterly Total Debt fell 17.14% year-over-year to $38.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $38.8 million (down 17.14% YoY) and the FY2025 annual result came in at $41.1 million, up 4.86% from the prior year.
  • Total Debt fell to $38.8 million in Q2 2026, from $39.4 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $46.8 million in Q2 2025 to a low of $34.2 million in Q3 2022.
  • A 5-year average of $39.0 million and a median of $38.1 million in 2022 frame the typical range for Total Debt.
  • Annual changes were most pronounced in 2025 — Total Debt advanced 26.07% — and 2026, when it fell 17.14%.
  • Tracing INCY's Total Debt over 5 years: stood at $36.5 million in 2022, then increased by 5.16% to $38.4 million in 2023, then increased by 2.12% to $39.2 million in 2024, then advanced by 4.86% to $41.1 million in 2025, then retreated by 5.67% to $38.8 million in 2026.
  • The last three Total Debt figures came in at $38.8 million (Q2 2026), $39.4 million (Q1 2026), and $41.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 591.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.07 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.34 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 546.77 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 38.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38.81 Mn
Mar 31, 2026 39.38 Mn
Dec 31, 2025 41.14 Mn
Sep 30, 2025 45.62 Mn
Jun 30, 2025 46.84 Mn
Mar 31, 2025 41.72 Mn
Dec 31, 2024 39.24 Mn
Sep 30, 2024 40.34 Mn
Jun 30, 2024 37.16 Mn
Mar 31, 2024 37.16 Mn
Dec 31, 2023 38.42 Mn
Sep 30, 2023 36.82 Mn
Jun 30, 2023 37.51 Mn
Mar 31, 2023 37.17 Mn
Dec 31, 2022 36.54 Mn
Sep 30, 2022 34.19 Mn
Jun 30, 2022 36.92 Mn
Mar 31, 2022 37.87 Mn
Dec 31, 2021 37.01 Mn
Sep 30, 2021 38.22 Mn